University of Minnesota Medical School

Immusoft's ISP-001, an autologous B cell therapy engineered to express iduronidase enzyme, shows positive safety and initial activity in first-in-human MPS I trial without requiring preconditioning or immunosuppression.

A national assessment finds that only 41.8% of hematology/oncology fellows receive specific training for community-based careers, despite 80-85% of cancer patients receiving treatment in community settings.

The GRADE study, a large clinical trial comparing four diabetes medications added to metformin, found that insulin glargine and liraglutide performed modestly better at maintaining target blood glucose levels over five years.

A University of Minnesota study found that hydroxychloroquine did not prevent COVID-19 infection in high-risk healthcare workers, with 5.9% of the hydroxychloroquine group and 7.9% of the placebo group developing the virus.